Pricing Log in Create free account

REGENXBIO Inc. (RGNX) vs Shattuck Labs, Inc. (STTK)

REGENXBIO Inc. and Shattuck Labs, Inc. are both Biotechnology companies. REGENXBIO Inc. and Shattuck Labs, Inc. are of similar size ($508.5M and $493.9M). Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against −4.59%. Shattuck Labs, Inc. has the higher net margin (0.00% vs −113.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Shattuck Labs, Inc. leads on 10 and REGENXBIO Inc. on 6.

Valuation

Metric RGNX STTK Biotechnology median
P/E n/m n/m 10.96
P/S 3.29 160.15 9.52
P/B 3.42 4.64 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 1.69 125.13 9.00
Earnings yield (41.47%) (10.36%) (32.09%)
Free cash flow yield (30.61%) (5.55%) (22.62%)

Profitability

Metric RGNX STTK Biotechnology median
Gross margin 87.54% 100.00% 68.51%
Operating margin (95.68%) 0.00% 0.00%
Net margin (113.85%) 0.00% 0.00%
Free cash flow margin (100.58%) 0.00% 0.00%
Return on equity (113.24%) (47.20%) (50.12%)
Return on assets (35.36%) (43.93%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RGNX STTK Biotechnology median
Revenue growth (TTM) (4.59%) 106.48% 6.78%
EPS growth (last fiscal year) 18.08% 53.02% 29.88%
Revenue growth, 5-year CAGR 1.97% (36.82%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RGNX STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.74 15.80 4.74
Net debt to EBITDA 1.58 1.62 1.01

Dividend

Metric RGNX STTK Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric RGNX STTK Biotechnology median
Market cap 508.48m 493.93m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack